Colorado BioScience Association (CBSA) will highlight M&A activity and growth in Colorado’s thriving medical device industry at the CBSA Medical Device Symposium. Medical device sector dealmaking, trends, legal implications and policy discussions make up the agenda for the symposium, scheduled for Thursday, January 29th at the Omni Interlocken Resort in Broomfield.
Highlights of the CBSA Medical Device Symposium, sponsored by Snell & Wilmer Law Offices, include:
- Insight on Medtronic’s acquisition of Covidien
- New data on the medical device industry in Colorado
- Information on the impact of federal policy on the state’s medical device industry
April Giles, President & CEO of CBSA, says:
“Colorado’s medical device industry is booming, with device and diagnostics employment increasing by 23% between 2007 and 2012. This important sector is a success story for Colorado and our bioscience community. CBSA is proud to bring leading experts on medical device industry deals and trends together to share success stories and strategies for future growth.”
Featured Speakers:
- Chris Cleary, Vice President of Corporate Development for Medtronic. Cleary will give insights into the Medtronic acquisition of Covidien.
- Erik Reynolds, Senior Manager, Healthcare Segment, EY. Reynolds will present EY’s Pulse of the Industry Report, outlining industry trends and providing an outlook for the medical device community in 2015.
- Erik Kintner, Partner, Snell & Wilmer. Kintner will lead a panel discussion on federal policy and implications for the state’s medical technology sector.
Supporting sponsors of the symposium include: EY, Fisher Scientific and Fitzsimons Redevelopment Authority.
The conference will be held from 1-6 p.m. at the Omni Interlocken Resort, 500 Interlocken Boulevard, in Broomfield. Registration is $50 for CBSA members and $100 for non-members.
Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn
About the Colorado BioScience Association
The Colorado BioScience Association (CBSA) is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, advocate for policies that support a strong bioscience industry in the state, and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
